Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Clinical trial NCT06996119 · RECRUITING
Trial details
- NCT number
- NCT06996119
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-12
- Primary completion
- 2027-05-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.